Analyst consensus rating
BioCardia Analyst Rating: none
Direct answer
BioCardia's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $15.50.
Forecast evidence checked October 17, 2026.
Get free BioCardia email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.92
- Average price target
- $15.50
- High price target
- $25.00
- Low price target
- $6.00
- Low target gap
- +552.1%
- Target upside
- +1,584.6%
- High target gap
- +2,617.1%
- Target range width
- 2,065%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BioCardia?
BioCardia has a verified none consensus. The same dataset has an average price target of $15.50.
How far are BioCardia's low and high targets from the recorded price?
The low target implies +552.1%, while the high target implies +2,617.1%.
How many analysts are included in BioCardia's consensus?
The verified consensus includes 2 analysts.
How is BioCardia's target upside or downside calculated?
The average target of $15.50 is divided by the recorded price of $0.92, then one is subtracted to produce +1,584.6%. This does not guarantee a future return.
When was BioCardia's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.